| 51 | 15072700 | Absence of ion channels CACN1AS and SCN4A mutations in thyrotoxic hypokalemic periodic paralysis. | Thyroid | 2004 Mar |
1 |
| 52 | 15185439 | [From gene to diseases; hypokalemic periodic paralysis]. | Ned Tijdschr Geneeskd | 2004 May 22 |
3 |
| 53 | 15498118 | [Effect of sodium butyrate in combination with ATRA on the proliferation/differentiation of MDS cell line SKM-1]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2004 Oct |
4 |
| 54 | 15557532 | SCN4A-associated hypokalemic periodic paralysis merits a trial of acetazolamide. | Neurology | 2004 Nov 23 |
1 |
| 55 | 15562257 | State-dependent mibefradil block of Na+ channels. | Mol Pharmacol | 2004 Dec |
1 |
| 56 | 15587392 | The effect of sodium butyrate in combination with ATRA on the proliferation/differentiation of SKM-1. | J Huazhong Univ Sci Technolog Med Sci | 2004 |
3 |
| 57 | 15596759 | New mutations of SCN4A cause a potassium-sensitive normokalemic periodic paralysis. | Neurology | 2004 Dec 14 |
3 |
| 58 | 15642860 | Familial periodic paralysis and Charcot-Marie-Tooth disease in a 7-generation family. | Arch Neurol | 2005 Jan |
1 |
| 59 | 15864116 | Preferred mexiletine block of human sodium channels with IVS4 mutations and its pH-dependence. | Pharmacogenet Genomics | 2005 Apr |
1 |
| 60 | 16174788 | Molecular modeling of local anesthetic drug binding by voltage-gated sodium channels. | Mol Pharmacol | 2005 Dec |
2 |
| 61 | 16713241 | Recombinant human voltage-gated skeletal muscle sodium channels are pharmacologically functional in planar lipid bilayers. | Biosens Bioelectron | 2007 Jan 15 |
7 |
| 62 | 16800929 | [ERK pathway change in the differentiation of human MDS cell lines SKM-1 induced by sodium butyrate]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2006 Jun |
12 |
| 63 | 17237232 | A cation-pi interaction discriminates among sodium channels that are either sensitive or resistant to tetrodotoxin block. | J Biol Chem | 2007 Mar 16 |
1 |
| 64 | 17638382 | Individual variation and hormonal modulation of a sodium channel beta subunit in the electric organ correlate with variation in a social signal. | Dev Neurobiol | 2007 Sep 1 |
1 |
| 65 | 18079277 | State- and use-dependent block of muscle Nav1.4 and neuronal Nav1.7 voltage-gated Na+ channel isoforms by ranolazine. | Mol Pharmacol | 2008 Mar |
6 |
| 66 | 18162704 | The genotype and clinical phenotype of Korean patients with familial hypokalemic periodic paralysis. | J Korean Med Sci | 2007 Dec |
1 |
| 67 | 18203179 | Severe neonatal non-dystrophic myotonia secondary to a novel mutation of the voltage-gated sodium channel (SCN4A) gene. | Am J Med Genet A | 2008 Feb 1 |
3 |
| 68 | 18718068 | [Effect of decitabine combined with Trichostatin A on MDS cell line SKM-1 in vitro]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2008 Aug |
8 |
| 69 | 19876661 | Isolated eyelid closure myotonia in two families with sodium channel myotonia. | Neurogenetics | 2010 May |
1 |
| 70 | 20038812 | Human voltage-gated sodium channel mutations that cause inherited neuronal and muscle channelopathies increase resurgent sodium currents. | J Clin Invest | 2010 Jan |
4 |
| 71 | 20445432 | A case of paramyotonia congenita without periodic paralysis: electrophysiological and molecular genetic studies. | Neurologist | 2010 May |
2 |
| 72 | 20580661 | Effects of a new potent analog of tocainide on hNav1.7 sodium channels and in vivo neuropathic pain models. | Neuroscience | 2010 Aug 25 |
1 |
| 73 | 20590641 | Molecular determinants of state-dependent block of voltage-gated sodium channels by pilsicainide. | Br J Pharmacol | 2010 Jul |
3 |
| 74 | 20634695 | Skeletal muscle channelopathies: nondystrophic myotonias and periodic paralysis. | Curr Opin Neurol | 2010 Oct |
1 |
| 75 | 20693878 | Block of neuronal Na+ channels by antidepressant duloxetine in a state-dependent manner. | Anesthesiology | 2010 Sep |
1 |
| 76 | 21081490 | Possible roles of exceptionally conserved residues around the selectivity filters of sodium and calcium channels. | J Biol Chem | 2011 Jan 28 |
1 |
| 77 | 21176362 | [Effect of sodium valproate on human myelodysplastic syndrome cell line SKM-1 and its mechanism]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2010 Dec |
3 |
| 78 | 21204798 | Myotonia congenita and myotonic dystrophy in the same family: coexistence of a CLCN1 mutation and expansion in the CNBP (ZNF9) gene. | Clin Genet | 2011 Dec |
2 |
| 79 | 21317558 | Ranolazine block of human Na v 1.4 sodium channels and paramyotonia congenita mutants. | Channels (Austin) | 2011 Mar-Apr |
1 |
| 80 | 21654192 | Azacitidine-resistant SKM1 myeloid cells are defective for AZA-induced mitochondrial apoptosis and autophagy. | Cell Cycle | 2011 Jul 15 |
5 |
| 81 | 21802953 | Searching for novel anti-myotonic agents: pharmacophore requirement for use-dependent block of skeletal muscle sodium channels by N-benzylated cyclic derivatives of tocainide. | Neuromuscul Disord | 2012 Jan |
4 |
| 82 | 22033299 | Enhancing effects of salicylate on quinidine-induced block of human wild type and LQT3 related mutant cardiac Na+ channels. | Biomed Res | 2011 Oct |
2 |
| 83 | 22250216 | Biophysical characterization of M1476I, a sodium channel founder mutation associated with cold-induced myotonia in French Canadians. | J Physiol | 2012 Jun 1 |
1 |
| 84 | 22253645 | Hypokalemic periodic paralysis; two different genes responsible for similar clinical manifestations. | Korean J Pediatr | 2011 Nov |
1 |
| 85 | 22399596 | Antiproliferative and antitumor effects of azacitidine against the human myelodysplastic syndrome cell line SKM-1. | Anticancer Res | 2012 Mar |
6 |
| 86 | 22403541 | Molecular Insights into the Local Anesthetic Receptor within Voltage-Gated Sodium Channels Using Hydroxylated Analogs of Mexiletine. | Front Pharmacol | 2012 |
1 |
| 87 | 22522923 | Sensitivity of cloned muscle, heart and neuronal voltage-gated sodium channels to block by polyamines: a possible basis for modulation of excitability in vivo. | Channels (Austin) | 2012 Jan-Feb |
4 |
| 88 | 22577154 | BCL2L10 is a predictive factor for resistance to azacitidine in MDS and AML patients. | Oncotarget | 2012 Apr |
4 |
| 89 | 22617007 | A sodium channel myotonia due to a novel SCN4A mutation accompanied by acquired autoimmune myasthenia gravis. | Neurosci Lett | 2012 Jun 21 |
3 |
| 90 | 22849704 | An improved synthesis of m-hydroxymexiletine, a potent mexiletine metabolite. | Drug Metab Lett | 2012 Jun 1 |
3 |
| 91 | 22967374 | [Establishment of human homoharringtonine-resistant SKM-1 cell line and its biological characteristics]. | Zhonghua Xue Ye Xue Za Zhi | 2012 Jun |
5 |
| 92 | 23093371 | Methylation of Wnt antagonist genes: a useful prognostic marker for myelodysplastic syndrome. | Ann Hematol | 2013 Jan |
2 |
| 93 | 23417379 | Double trouble in a patient with myotonia. | BMJ Case Rep | 2013 Feb 14 |
1 |
| 94 | 23821303 | Voltage-gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin-induced peripheral neurotoxicity: results from a prospective multicenter study. | Cancer | 2013 Oct 1 |
2 |
| 95 | 24302985 | Direct evidence that scorpion α-toxins (site-3) modulate sodium channel inactivation by hindrance of voltage-sensor movements. | PLoS One | 2013 |
4 |
| 96 | 24607901 | Mechanism of tetrodotoxin block and resistance in sodium channels. | Biochem Biophys Res Commun | 2014 Mar 28 |
6 |
| 97 | 24608798 | Reversal of bortezomib resistance in myelodysplastic syndrome cells by MAPK inhibitors. | PLoS One | 2014 |
3 |
| 98 | 24704559 | Artesunate induces apoptosis through caspase-dependent and -independent mitochondrial pathways in human myelodysplastic syndrome SKM-1 cells. | Chem Biol Interact | 2014 Aug 5 |
1 |
| 99 | 24939454 | Focal and abnormally persistent paralysis associated with congenital paramyotonia. | BMJ Case Rep | 2014 Jun 17 |
2 |
| 100 | 24943082 | [Normokalemic periodic paralysis lasting for two weeks: a severe form of sodium channelopathy with M1592V mutation]. | Rinsho Shinkeigaku | 2014 |
2 |